Table 1.
Non-imputed effect estimates2 |
Imputed effect esti mates |
||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Controls | TMD cases | Site-adjusted effect3 | Fully adjusted effect4 | Fully adjusted effect | |||||||||||
Stimulus | Units and potential range |
n | mean | se | n | mean | se | P-value1 | SOR55 | 95%CI66 | SOR | 95%CI | n | SOR | 95%CI |
Pressure pain threshold 7 | |||||||||||||||
Temporalis | kPa, 50–600 | 1601 | 217.92 | 2.12 | 168 | 148.23 | 4.06 | <0.0001 | 4.1 | 3.1,5.4 | 3.7 | 2.7, 4.9 | 1793 | 3.8 | 2.9, 5.1 |
Masseter | kPa, 50–600 | 1605 | 201.01 | 1.98 | 160 | 141.97 | 4.43 | <0.0001 | 3.4 | 2.6,4.5 | 3.0 | 2.3, 4.0 | 1793 | 3.4 | 2.5, 4.5 |
TM joint | kPa, 50–600 | 1579 | 184.58 | 1.72 | 157 | 133.84 | 3.67 | <0.0001 | 3.5 | 2.7,4.6 | 3.3 | 2.5, 4.4 | 1793 | 3.7 | 2.8, 4.9 |
Trapezius | kPa, 100–600 | 1573 | 372.93 | 3.70 | 160 | 260.71 | 7.90 | <0.0001 | 2.8 | 2.2,3.5 | 2.6 | 2.0, 3.3 | 1793 | 2.6 | 2.1, 3.4 |
Lateral epicondyle | kPa,100–600 | 1573 | 389.18 | 3.69 | 164 | 298.88 | 10.00 | <0.0001 | 2.4 | 1.9,3.0 | 2.2 | 1.7, 2.7 | 1793 | 2.2 | 1.8, 2.8 |
Mechanical cutaneous pain | |||||||||||||||
Threshold7 | mN, 8–512 | 1540 | 269.74 | 4.30 | 172 | 170.45 | 10.31 | <0.0001 | 2.1 | 1.7,25 | 2.0 | 1.6, 2.5 | |||
Single stimulus ratings | |||||||||||||||
256mN probe | ratings, 0–100 | 1562 | 8.83 | 0.32 | 176 | 13.76 | 1.20 | <0.0001 | 1.3 | 1.2,15 | 1.5 | 1.3, 1.7 | 1742 | 1.5 | 1.3, 1.7 |
512mN probe | ratings, 0–100 | 1464 | 14.79 | 0.46 | 161 | 21.62 | 1.63 | <0.0001 | 1.3 | 1.2,15 | 1.5 | 1.3, 1.8 | 1742 | 1.5 | 1.3, 1.8 |
Overall ratings of 10 stimuli | |||||||||||||||
256mN probe | ratings, 0–100 | 1563 | 18.40 | 0.53 | 176 | 28.62 | 1.82 | <0.0001 | 1.4 | 1.3,17 | 1.7 | 1.4, 1.9 | 1742 | 1.7 | 1.4, 1.9 |
512mN probe | ratings, 0–100 | 1461 | 31.36 | 0.71 | 161 | 43.69 | 2.17 | <0.0001 | 1.5 | 1.3,17 | 1.7 | 1.4, 2.0 | 1742 | 1.7 | 1.4, 2.0 |
Aftersensation ratings | |||||||||||||||
15 s, 256mN probe | ratings, 0–100 | 1562 | 2.90 | 0.19 | 174 | 6.68 | 0.98 | <0.0001 | 1.3 | 1.2,15 | 1.4 | 1.2, 1.6 | 1742 | 1.4 | 1.2, 1.6 |
30 s, 256mN probe | ratings, 0–100 | 1563 | 1.35 | 0.12 | 175 | 3.23 | 0.72 | <0.0001 | 1.2 | 1.1,14 | 1.3 | 1.1, 1.5 | 1742 | 1.3 | 1.1, 1.5 |
15 s, 512mN probe | ratings, 0–100 | 1456 | 6.62 | 0.33 | 161 | 13.75 | 1.40 | <0.0001 | 1.5 | 1.3,17 | 1.6 | 1.4, 1.9 | 1742 | 1.5 | 1.3, 1.7 |
30 s, 512mN probe | ratings, 0–100 | 1453 | 3.56 | 0.22 | 161 | 7.16 | 0.99 | <0.0001 | 1.3 | 1.2,15 | 1.4 | 1.2, 1.6 | 1742 | 1.3 | 1.2, 1.5 |
Temporal summation | |||||||||||||||
256mN probe | Δ ratings, ±100 | 1560 | 9.56 | 0.31 | 176 | 14.86 | 1.05 | <0.0001 | 1.4 | 1.2,15 | 1.5 | 1.3, 1.7 | 1742 | 1.5 | 1.3, 1.7 |
512mN probe | Δ ratings, ±100 | 1461 | 16.56 | 0.42 | 161 | 22.07 | 1.26 | <0.0001 | 1.3 | 1.1,15 | 1.4 | 1.2, 1.7 | 1742 | 1.4 | 1.2, 1.6 |
P-values are from analysis of variance model comparing mean values of putative risk factor between cases and controls, with adjustment for study site.
Non-imputed effect estimates are for complete case analysis using numbers of subjects in columns headed n.
Site-adjusted effects were computed in logistic regression models where the putative risk factor as the main explanatory variable and study site as covariate.
Fully-adjusted effects were computed in logistic regression models that additionally include covariates of age group, gender and race/ethnicity.
5 SOR is standardized odds ratio from a logistic regression model evaluating the linear effect of the risk factor that was standardized by z-score transformation
95% confidence interval for SOR
Negative z-scores used for standardized odds ratios which therefore represent increase in odds of TMD associated with reduction of 1 sd in the value of the variable